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Abstract
Background: Patients with impaired glucose tolerance (IGT) have an increased risk of
cardiovascular disease (CVD) that is independent of traditional risk factors. Hence, slightly elevated
glucose levels, even in the non-diabetic range, might be associated with increased macrovascular
disease.
Methods: Within the Northern Sweden MONICA project a population survey was performed in
1986. Electrocardiograms (ECG's) were recorded for half of the survey (n = 790) and oral glucose
test was carried out in 78 % of those. The association between subjects with ECG's indicating
previously unknown myocardial infarction (ukMI), IGT and conventional risk factors were analyzed
by logistic regression for men and women separately, adjusting for age, smoking,
hypercholesterolemia and hypertension.
Results: Impaired glucose tolerance was significantly more common among women with ukMI, but
not in men, compared to the group with normal ECG. In men, no variable was significantly
associated with ukMI although the odds ratio (OR) for hypercholesterolemia was of borderline
significance, 3.2 (95% confidence interval (CI) 0.9 to 11). The OR of having ukMI was 4.1 (CI 1.1 to
15) in women with IGT compared to women with normal glucose tolerance after multiple
adjustment. The OR for hypertension was of borderline significance; 3.3 (CI 0.97 to 11).
Conclusion: We found that IGT was associated with ECG findings indicating silent myocardial
infarction in women in a middle-aged general population in northern Sweden. The results persisted
even after adjusting for known risk factors.
Background
Diabetes contributes strongly to the risk of CVD with a
risk that is increased four to six times, both for stroke and
myocardial infarction [1]. The increase in risk for myocar-
dial infarction seem to be more pronounced in women
than in men [2].
The prevalence of IGT in the general population is 2–3
times higher than that of previously unknown diabetes,
which, in turn, is as common as known diabetes [3].
Patients with impaired glucose tolerance have an
increased risk of CVD that is independent of traditional
risk factors such as hypertension, smoking and hypercho-
lesterolemia [4] and it has been suggested that slightly ele-
vated glucose levels, even in the non-diabetic range, might
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the risk of CVD is already present in the prediabetic state
[5]. Several publications have focused on the relationship
between IGT and coronary heart disease (CHD). The
results have indicated that ethnicity, sex and age might be
factors that modify the strength of the risk of CHD with
impaired glucose tolerance [6–11].
The aim of the present investigation was to further evalu-
ate the possible relation between IGT and CHD. There-
fore, we examined ECG's to identify signs of clinically
undiagnosed myocardial infarction together with cardio-
vascular risk factors in a randomly selected population of
men and women from northern Sweden, a region with an
ethnically homogenous population and a high incidence
of cardiovascular disease [12].
Methods
This study was performed within the framework of the
Northern Sweden MONICA project which, in turn, is a
part of the WHO MONICA Project (Monitoring of Trends
and Determinants in Cardiovascular Disease) [13]. Dur-
ing January to April 1986, a population was screened for
cardiovascular risk factors. A total of 2000 individuals in
the 25 to 64 year range were invited. Within each age
group (25–34, 35–44, 45–54, 55–64 years) 250 men and
250 women were randomly selected from continuously
updated population registers in Norrbotten and Väster-
botten, the two northernmost provinces of Sweden. They
were invited by letter to an examination. If they did not
attend, a reminder with a new appointment was sent. Peo-
ple who still did not come, were contacted by telephone
to ascertain reasons for reluctance to attend and to get
basic information on social background and risk factors.
The participants were asked to complete a questionnaire
with items on, inter alia, social background, smoking hab-
its, medical history and intake of drugs. The questionnaire
was returned on the site of the survey, which was per-
formed by two mobile teams in local health centres (or
corresponding) throughout the MONICA area. ECG's
were recorded for the Västerbotten part of the population.
Seven hundred ninety subjects from Västerbotten partici-
pated in the study (79 % of all invited). Six hundred sev-
enteen subjects, without known diabetes, underwent a 75
g oral glucose tolerance test (OGTT) with measurement of
plasma glucose [3]. The results were classified according
to WHO criteria from 1999 [14]. Anthropometric meas-
urements and biochemical analyses were as previously
described [15]. Clinically diagnosed myocardial infarc-
tion, or known MI (kMI), was defined by a positive
answer to the question "Have you ever had a myocardial
infarction?". Clinically diagnosed, or known diabetes, was
defined by a positive answer to the question "Do you have
diabetes ?". A validation study of 70 incident diabetes
cases in this cohort using clinical case records show these
answers to be highly accurate (unpublished data). Hyper-
tension was defined as systolic blood pressure greater than
160 mm Hg or diastolic blood pressure greater than 95
mm Hg or a positive answer to the question "Are you
being treated with pharmaceutical drugs for high blood
pressure". Hypercholesterolemia was defined as total cho-
lesterol values more than 6,5 mmol/l. Subjects smoking
more than 1 cigarette per day were defined as regular
smokers.
The Northern Sweden Monica Study has been approved
by the Research Ethics Committee of Umeå University
and the data handling procedures by the National Com-
puter Data Inspection Board.
Electrocardiography
All electrocardiograms (ECG's) were recorded with a Car-
diovit CS-6 microprocessor-based electrocardiograph
(Schiller AG, Basel, Switzerland). Twelve leads were
recorded for 10 seconds and used for interpretation by the
CS-6 recorder. Original readings were printed on paper
(paper speed 50 mm/s) together with an averaged ECG
and a diagnostic statement made by the computer. ECG's
were asessed according to the Minnesota Code by two
trained observers and Q/QS-wave; codes 1.1–1.3 were
designated as myocardial infarction. ECG's from two sub-
jects were coded differently by the observers and were
therefore excluded from the MI group.
Statistical analysis
Continuous data are presented as means and SD. Students
t-test and χ2 were used to test for differences between sub-
jects with normal ECG and subjects with ukMI. In a step-
wise logistic regression with ukMI as dependent variable,
traditional risk factors (hypertension, smoking, hypercho-
lesterolemia) and the occurrence of IGT were entered as
dichotomous independent variables and age as a continu-
ous variable. Results are given as odds ratios with 95 %
confidence intervals. All statistical analysis were carried
out with the SPSS programme, version 10.1.
Results
Table 1 shows baseline characteristics of 790 subjects, 25
to 64 years of age. Both sexes were evenly represented. Pre-
viously known MI (kMI) was present in 2.7 %, hyperten-
sion in 18,5 %, hypercholesterolemia in 36.3 % and
diabetes in 2.8 %. Nearly one quarter was smokers and
more than 10 % used smokeless tobacco. Half of the pop-
ulation was overweight and with increased waist circum-
ference. Mean serum cholesterol was high, 6.2 mmol/l.
A gender-specific analysis are shown in table 2. Clinically
diagnosed myocardial infarction and diabetes were more
prevalent in men. Cigarette smoking were more commonPage 2 of 7
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pared to men. The number of subjects with IGT was much
higher in women.
An OGTT was carried out in 617 subjects, showing IGT in
8.6 % and unknown diabetes in 2.3 %. A gender-specific
analysis of this population did not differ significantly
regarding age, anthropometric variables or biochemical
markers compared to the total study population shown in
table 1 and 2 (table 3).
All ECG's not interpreted as MI were considered normal
(93.8 %). Interestingly, there were twice as many subjects
with ECG indicating MI (ukMI) that had not been clini-
cally diagnosed than with known infarctions (kMI). The
majority of kMI's were not detected on ECG (Table 4). The
21 subjects with kMI were excluded from further analysis.
A gender-specific analysis comparing subjects with nor-
mal ECG to ukMI subjects are shown in Table 5. Subjects
of both sexes with ukMI were older and had a greater bur-
den of previous CVD than did subjects with normal
ECG's. Diabetes and hypercholesterolemia were more
prevalent in men with ukMI than in women. Body mass
index and waist-hip ratio were higher in subjects with
ukMI, more so in women than in men. There was a ten-
dency to higher lipid levels in the ukMI group, at least in
women. The number of subjects with IGT was signifi-
cantly higher in the ukMI group in women, but not in
men compared to the group with normal ECG.
The association between ukMI and sex, age, smoking,
hypercholesterolemia, hypertension and IGT was ana-
lyzed in a multiple logistic regression model. 617 subjects
with complete data sets were included. None of the varia-
Table 1: Characteristics of the total study population, 25 to 64 
years of age in the Northern Sweden MONICA population survey 
in 1986. Mean (SD) or proportions (%).
Subjects (n) 790
Age (years) 45.2 (11.3)
Sex
Men 409 (51.8 %)
Women 381 (48.2 %)
Previous disorders
Clinically diagnosed myocardial infarction (kMI) 21 (2.7 %)
Hypertension 146 (18.5 %)
Hypercholesterolemia 287 (36.3 %)
Diabetes 22 (2.8 %)
Tobacco use
Current cigarette smoker 179 (22.8 %)
Current smokeless tobacco user 80 (10.6 %)
Anthropometric variables
Height (cm) 170.3 (9.2)
Weight (kg) 72.8 (13.3)
BMI (kg/m2) 25 (3.8)
Hip circumference (cm) 99.2 (7.4)
Waist circumference (cm) 88.1 (11.6)
Waist-hip ratio 0.9 (0.1)
Biochemical markers (mmol/l)
Total cholesterol 6.2 (1.3)
HDL cholesterol 1.2 (0.3)
Triglycerides (n = 495) 1.3 (0.9)
Fasting plasma glucose (n = 774) 5.1 (1.4)
2 hour postload plasma glucose (n = 629) 5.5 (2.0)
Glucose tolerance (n = 617)
Normal 550 (89.1 %)
Impaired glucose tolerance 53 (8.6 %)
Diabetes 14 (2.3 %)
ECG
Normal 741 (93.8 %)
MI 49 (6.2 %)
BMI = body mass index. HDL = high-density lipoprotein. MI = 
myocardial infarction (Q/QS wave; Minnesota code 1.1–1.3). kMI = 
known myocardial infarction.
Table 2: Characteristics of the study population, men and 
women, 25 to 64 years of age in the Northern Sweden MONICA 
population survey in 1986. Mean (SD) or proportions (%).
Men Women
Age (years) 45.7 (11.4) 44.8 (11.2)
Previous disorders
Clinically diagnosed myocardial 
infarction (kMI)
18 (4.5 %) 3 (0.8 %)
Hypertension 81 (19.8 %) 65 (17.1 %)
Hypercholesterolemia 148 (36.2 %) 139 (36.5 %)
Diabetes 16 (4.0 %) 6 (1.6 %)
Tobacco use
Current cigarette smoker 80 (19.7 %) 99 (26.2 %)
Current smokeless tobacco user 76 (19.6 %) 4 (1.1 %)
Anthropometric variables
Height (cm) 176.6 (6.8) 163.5 (6.0)
Weight (kg) 79 (11.0) 66 (12.1)
BMI (kg/m2) 25.3 (3.2) 24.7 (4.4)
Hip circumference (cm) 99.1 (5.6) 99.2 (9.0)
Waist circumference (cm) 92.5 (9.1) 83.2 (12.1)
Waist-hip ratio 0.9 (0.1) 0.8 (0.1)
Biochemical markers (mmol/l)
Total cholesterol 6.2 (1.2) 6.2 (1.3)
HDL cholesterol 1.1 (0.3) 1.4 (0.4)
Triglycerides (n = 495) 1.5 (1.1) 1.1 (0.7)
Fasting plasma glucose (n = 774) 5.3 (1.8) 4.8 (0.7)
2 hour postload plasma glucose 
(n = 629)
5.3 (2.2) 5.8 (1.9)
Glucose tolerance (n = 617)
Normal 290 (91.8 %) 260 (86.4 %)
Impaired glucose tolerance 19 (6.0 %) 34 (11.3 %)
Diabetes 7 (2.2 %) 7 (2.3 %)
ECG
Normal 381 (93.2 %) 360 (94.5 %)
MI 28 (6.8. %) 21 (5.5 %)
BMI = body mass index. HDL = high-density lipoprotein. MI = 
myocardial infarction (Q/QS wave; Minnesota code 1.1–1.3). kMI = 
known myocardial infarction.Page 3 of 7
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ukMI (table 6).
Men and women were analyzed separately and the results
are shown in Table 7. In men, no variable was signifi-
cantly associated with ukMI although the odds ratio for
hypercholesterolemia was of borderline significance; 3.22
(CI 0.92 ; 11.22). In women, IGT was significantly associ-
ated with ukMI and hypertension had a tendency towards
association. The odds ratio of having ukMI was 4.14 (CI
1.13; 15.14) in women with IGT compared to women
with normal glucose tolerance. The odds ratio for hyper-
tension was of borderline significance; 3.33 (CI 0.97;
11.43). The results were similar if subjects with ST/T
changes and left ventricular hypertrophy were excluded
from the "normal ECG " group. If, on the other hand, ST/
T changes are included in the MI group no significant
association between any variable was seen (data not
shown).
Discussion
Our findings indicate that previously unknown Q-wave
infarction is considerably more common in women 25–
64 years of age with impaired glucose tolerance than in
women with normal glucose tolerance, even after adjust-
ment for traditional risk factors. No such relationship was
noted in men. The total number of participants was rather
small which is a limitation of the study but the attendence
rate of 80 % is in accordance with other major population
surveys. The variables measured are strictly validated
according to WHO criteria [3].
Cross-sectional studies concerning resting ECG abnormal-
ities indicating IHD in subjects with IGT have reported
varying results. In younger south Asian men (40–54 years)
settled overseas, major Q-waves were strongly associated
with glucose intolerance and hyperinsulinemia [7]. This
association was less strong for European men in the same
study. In a Chinese population, IGT was associated with
ECG abnormalities in both men and women, but the ECG
criteria used also included T-wave abnormalities and com-
plete left bundle branch block, which differs from the
stricter Q-wave criteria used in our study [8]. Data from
the Rancho Bernardo Study, an older population of white
subjects, showed that ECG abnormalities were more
common in subjects with non-insulin dependent diabetes
(NIDDM) but not in those with IGT. Also in this study,
ECG criteria were wider than our criteria [9]. In the San
Luis Valley Diabetes Study, 20–74-year-old Hispanics and
non-Hispanic whites of both sexes were studied. An asso-
ciation between NIDDM, but not IGT, with mainly Q/QS
waves was seen [10]. A study of North American white
males, aged 40–59 years, could not show any association
between blood glucose and major ECG abnormalities
indicating MI [11].
Hence, no consistent data concerning association
between IGT and silent myocardial infarctions have been
shown and only few studies have included women. To our
knowledge no European data have been published. In
most studies, MI's were somewhat more common in sub-
jects with IGT, although not reaching conventional levels
of significance. This indicates a problem of statistical
power and perhaps differing impact of blood glucose
Table 3: Characteristics of the glucose tolerance tested subjects, 
men and women, 25 to 64 years of age in the Northern Sweden 
MONICA population survey in 1986. Mean (SD) or proportions 
(%).
Men Women
Age (years) 44.9 (11.3) 44.8 (11.2)
Previous disorders
Clinically diagnosed myocardial 
infarction (kMI)
10 (3.2 %) 2 (0.7 %)
Hypertension 60 (19.0 %) 52 (17.3 %)
Hypercholesterolemia 117 (37.0 %) 110 (36.5 %)
Tobacco use
Current cigarette smoker 57 (18.2 %) 73 (24.3 %)
Current smokeless tobacco user 56 (18.8 %) 2 (0.7 %)
Anthropometric variables
Height (cm) 176.5 (7.0) 163.7 (5.9)
Weight (kg) 79 (11.0) 66,4 (12.5)
BMI (kg/m2) 25.4 (3.3) 24.8 (4.5)
Hip circumference (cm) 99.1 (5.8) 99.5 (9.0)
Waist circumference (cm) 92.3 (9.1) 83.2 (12.6)
Waist-hip ratio 0.9 (0.1) 0.8 (0.1)
Biochemical markers (mmol/l)
Total cholesterol 6.2 (1.3) 6.2 (1.3)
HDL cholesterol 1.2 (0.3) 1.4 (0.4)
Triglycerides (n = 495) 1.3 (0.8) 1.1 (0.7)
Fasting plasma glucose (n = 774) 5.1 (1.1) 4.8 (0.5)
2 hour postload plasma glucose 
(n = 629)
5.3 (2.0) 5.8 (2.0)
ECG
Normal 299 (94.6 %) 286 (95.0 %)
MI 17 (5.4 %) 15 (5.0 %)
BMI = body mass index. HDL = high-density lipoprotein. MI = 
myocardial infarction (Q/QS wave; Minnesota code 1.1–1.3). kMI = 
known myocardial infarction.
Table 4: Comparison of clinically diagnosed myocardial 
infarctions and ECG indicating myocardial infarction (n = 771).
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differences between groups with χ2 or t-test.
A. Men
Normal ECG ukMI p
ECG classification (n) 364 (94.8 %) 20 (5.2 %)
Age (years) 44,4 (11.1) 52.2 (11) 0.002
Previous disorders
Hypertension 65 (17.9 %) 8 (40 %) 0.02
Hypercholesterolemia 122 (33.5 %) 12 (60 %) 0.02
Diabetes 9 (2.5 %) 3 (15 %) 0.002
Tobacco use
Current smoker 75 (20.8 %) 1 (5 %) 0.17
Current snuff user 71 (20.7 %) 3 (15.8 %) 0.61
Anthropometric variables
Height (cm) 176.9 (6.8) 176.3 (6.1) 0.68
Weight (kg) 78.9 (10.9) 81.5 (11.9) 0.30
BMI (kg/ m2) 25.2 (3.2) 26.2 (3.3) 0.19
Hip circumference (cm) 99 (5.7) 100.8 (5.1) 0.18
Waist circumference (cm) 92.2 (9.1) 95.3 (7.8) 0.14
Waist-hip ratio 0.93 (0.1) 0.95 (0.1) 0,19
Biochemical markers (mmol/l)
Total cholesterol 6.1 (1.3) 6.6 (0.8) 0,08
HDL 1.1 (0.3) 1.2 (0.2) 0,77
Triglycerides (n = 231) 1.4 (1.1) 1.9 (1.3) 0,12
Fasting plasma glucose 5.2 (1.6) 5.7 (2.5) 0.22
2 hour postload plasma glucose 5.3 (2.2) 5.1 (1.5) 0,71
Glucose tolerance (n = 304)
Impaired glucose tolerance 17 (5.9 %) 1 (7.1 %) 0,83
Diabetes 7 (2.4 %) 0
B. Women
Normal ECG ukMI p
ECG classification (n) 349 (95.4 %) 17 (4.6 %)
Age (years) 44 (11) 53.8 (7.1) <0.001
Previous disorders
Hypertension 54 (15.5 %) 8 (47.1 %) 0.003
Hypercholesterolemia 123 (35.2 %) 8 (47.1 %) 0.32
Diabetes 3 (0.9 %) 0 (0 %)
Tobacco use
Current smoker 92 (26.6 %) 3 (17.6 %) 0.41
Current snuff user 4 (1.2 %) 0
Anthropometric variables
Height (cm) 163.7 (6) 162.1 (5.0) 0.30
Weight (kg) 65.6 (11.8) 75.4 (15.9) 0.001
BMI (kg/m2) 24.4 (4.1) 28.7 (6.5) <0.001
Hip circumference (cm) 98.6 (8.3) 106.6 (12) <0.001
Waist circumference (cm) 82.6 (11.3) 92 (18.7) 0.001
Waist-hip ratio 0.84 (0.1) 0.86 (0.1) 0.2
Biochemical markers (mmol/l)
Total cholesterol 6.1 (1.3) 6.6 (1.4) 0.17
HDL 1.4 (0.4) 1.2 (0.3) 0.16
Triglycerides (n = 240) 1 (0.6) 1.4 (1) 0.04
Fasting plasma glucose 4.8 (0.7) 5 (0.4) 0.26
2 hour postload plasma glucose 5.7 (1.9) 6.9 (2.2) 0.02
Glucose tolerance (n = 293)
Impaired glucose tolerance 28 (10.1 %) 5 (38.5 %) 0.006
Diabetes 7 (2 %) 0
ECG = electrocardiogram. HDL = high-density lipoprotein. ukMI = unknown myocardial infarction. BMI = body mass indexPage 5 of 7
(page number not for citation purposes)
Cardiovascular Diabetology 2003, 2 http://www.cardiab.com/content/2/1/9abnormalities in different ethnic groups. Some of these
studies found that increases in risk were attenuated by
adjustement for other known risk factors. The wide defini-
tion of CHD based on ECG findings may also dilute effect
sizes. Our population-based study is thus the first to show
that in middle-aged European women, there is a strong
and independent relationship between IGT and previ-
ously unknown MI, defined by strict criteria.
The correlation between ECG findings indicating MI and
known infarctions is not strong. Major Q-waves were
shown to occur in only 43 % of subjects in whom old
myocardial infarcts were detected at autopsy, and Q/QS
abnormalities were found to be rather common in non Q-
wave infarctions as well [16]. Twenty to thirty percent of
major Q/QS infarctions are known to be silent [17]. More-
over, Q/QS abnormalities often disappear during recovery
from an acute myocardial infarction [16]. This was also
evident in our study where only a minority of reported
previous MI were classified as MI on ECG. Q/QS
abnormalities are also seen in other diseases affecting the
heart [18]. Interestingly, it was recently shown that left
ventricular hypertrophy (LVH) mass and wall thickness
increased with worsening glucose intolerance, an effect
that was more striking in women compared with men
[19]. Hence, since LVH can mimic MI this might lead to
misclassification bias in the ECG interpretation.
In the present investigation there are more than twice as
many subjects with ukMI as with kMI. This supports pre-
viously results in a population over 65 years of age [20].
Many kMI's were seen in the group with normal ECG, a
not surprising observation considering the findings men-
tioned. Specificity for Q/QS-infarctions was high but sen-
sitivity was low when ECG was compared to autopsy-
verified infarctions. Less than 60 % of all verified infarc-
tions were diagnosed in this material [16]. Thus, some inf-
arctions might be undetected in our material which could
lead to misclassification bias and a dilution of effect.
An increased IHD mortality has been described in subjects
with IGT, particularly in women [21]. In the DECODE
study, which included MONICA data from our survey,
IGT predicted mortality from all causes, CVD and CHD
[4]. Previous studies indicate that the risk of CVD is
increased at the time of diabetes diagnosis. The risk seem
to be independent of the duration of diabetes suggesting
that factors operating before the development of overt
diabetes contribute to the risk of CVD [5]. This was
recently shown in women where the risk for MI or stroke
was substantially increased before diagnosis of type 2 dia-
betes [22].
Hyperglycemia has also been suggested to be a direct
cause of some of the changes associated with atheroscle-
rosis [23,24], but several other factors could act as casual
links in this association such as impaired fibrinolysis and
high fibrinogen levels [25], high levels of leptin [26] as
well as others which have not been assessed in population
studies. These factors could link IGT to atherosclerosis
and thereby to the Q/QS abnormalities found in the
present investigation although the diverging results in
men and women are difficult to explain.
In conclusion, we found that IGT was associated with ECG
findings indicating silent myocardial infarction in women
in a middle-aged general population in northern Sweden.
The results persist even after adjusting for known risk fac-
tors. As encouraging results have recently been published
on the effect of life-style modification to prevent high risk
individuals from developing diabetes [27], our study
underlines that such efforts may also lead to decreased
cardiovascular risks. Also, more research is needed to
Table 6: Predictors of ukMI in a multiple logistic stepwise 
regression analysis
Risk factor OR 95 % CI
Male sex ? 0.88 0.39; 1.96
Age (years) 1.07 1.02; 1.13
Smoking 0.54 0.16; 1.88
Hypercholesterolemia 1.38 0.58; 3.30
Hypertension 2.00 0.85; 4.70
IGT 2.40 0.87; 6.68
ukMI = unknown myocardial infarction. OR (= odds ratio) calculated 
with all variables entered simultaneously, with age as a continous 
variable. CI = confidence interval. IGT = impaired glucose tolerance. 
Risk factor definitions were as described in Methods.
Table 7: Predictors of ukMI in a multiple logistic stepwise 
regression analysis
A. Men
OR for ukMI 95 % CI
Age (years) 1.07 1.01; 1.14
Smoking 0.28 0.04; 2.29
Hypercholesterolemia 3.22 0.92; 11.22
Hypertension 1.13 0.31; 4.07
IGT 0.68 0,08; 5.90
B. Women
OR for ukMI 95 % CI
Age (years) 1.09 1.01; 1.18
Smoking 0.97 0.19; 4.95
Hypercholesterolemia 0.60 0.16; 2.27
Hypertension 3.33 0.97; 11.43
IGT 4.14 1.13: 15.14
Conditions and abbreviations were as in table 4Page 6 of 7
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